Meristem Family Wealth’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | $2.32M | Sell |
14,317
-2,920
| -17% | -$424K | 0.25% | 45 |
|
|
2021
Q4 | $2.33M | Buy |
17,237
+43
| +0.3% | +$5.08K | 0.2% | 58 |
|
|
2021
Q3 | $1.85M | Buy |
17,194
+4,014
| +30% | +$459K | 0.18% | 65 |
|
|
2021
Q2 | $1.49M | Buy |
13,180
+4,359
| +49% | +$491K | 0.23% | 52 |
|
|
2021
Q1 | $955K | Sell |
8,821
-2,199
| -20% | -$235K | 0.19% | 65 |
|
|
2020
Q4 | $1.18M | Buy |
11,020
+2,202
| +25% | +$212K | 0.25% | 52 |
|
|
2020
Q3 | $772K | Sell |
8,818
-369
| -4% | -$34.7K | 0.2% | 69 |
|
|
2020
Q2 | $902K | Sell |
9,187
-476
| -5% | -$41.9K | 0.25% | 59 |
|
|
2020
Q1 | $736K | Sell |
9,663
-45
| -0.5% | -$3.83K | 0.23% | 64 |
|
|
2019
Q4 | $860K | Buy |
9,708
+383
| +4% | +$31.8K | 0.21% | 64 |
|
|
2019
Q3 | $706K | Sell |
9,325
-4,577
| -33% | -$314K | 0.19% | 77 |
|
|
2019
Q2 | $1.01M | Buy |
13,902
+4,843
| +53% | +$381K | 0.31% | 53 |
|
|
2019
Q1 | $730K | Sell |
9,059
-18
| -0.2% | -$1.47K | 0.25% | 56 |
|
|
2018
Q4 | $837K | Buy |
9,077
+56
| +0.6% | +$4.92K | 0.31% | 45 |
|
|
2018
Q3 | $853K | Buy |
9,021
+1
| +0% | +$95 | 0.29% | 44 |
|
|
2018
Q2 | $836K | Sell |
9,020
-1,670
| -16% | -$163K | 0.29% | 45 |
|
|
2018
Q1 | $1.01M | Buy |
10,690
+72
| +0.7% | +$7.91K | 0.36% | 40 |
|
|
2017
Q4 | $1.03M | Buy |
10,618
+1
| +0% | +$94 | 0.37% | 38 |
|
|
2017
Q3 | $943K | Sell |
10,617
-199
| -2% | -$15.1K | 0.38% | 39 |
|
|
2017
Q2 | $784K | Buy |
10,816
+1
| +0% | +$67 | 0.32% | 47 |
|
|
2017
Q1 | $705K | Buy |
10,815
+1
| +0% | +$63 | 0.28% | 50 |
|
|
2016
Q4 | $677K | Sell |
10,814
-1,947
| -15% | -$119K | 0.28% | 52 |
|
|
2016
Q3 | $805K | Buy |
12,761
+746
| +6% | +$48.3K | 0.34% | 43 |
|
|
2016
Q2 | $744K | Buy |
12,015
+1,116
| +10% | +$68K | 0.33% | 43 |
|
|
2016
Q1 | $623K | Sell |
10,899
-116
| -1% | -$6.46K | 0.28% | 49 |
|
|
2015
Q4 | $653K | Hold |
11,015
| – | – | 0.26% | 47 |
|
|
2015
Q3 | $599K | Hold |
11,015
| – | – | 0.31% | 37 |
|
|
2015
Q2 | $740K | Hold |
11,015
| – | – | 0.32% | 44 |
|
|
2015
Q1 | $645K | Sell |
11,015
-297
| -3% | -$17.9K | 0.27% | 54 |
|
|
2014
Q4 | $740K | Sell |
11,312
-1,500
| -12% | -$94.6K | 0.27% | 52 |
|
|
2014
Q3 | $740K | Sell |
12,812
-401
| -3% | -$22.3K | 0.32% | 44 |
|
|
2014
Q2 | $746K | Buy |
13,213
+3
| +0% | +$157 | 0.31% | 50 |
|
|
2014
Q1 | $679K | Sell |
13,210
-1,436
| -10% | -$72.6K | 0.3% | 51 |
|
|
2013
Q4 | $773K | Buy |
14,646
+1,338
| +10% | +$65.8K | 0.32% | 51 |
|
|
2013
Q3 | $595K | Sell |
13,308
-406
| -3% | -$18K | 0.27% | 56 |
|
|
2013
Q2 | $567K | Buy |
+13,714
| New | +$600K | 0.26% | 54 |
|
Other funds holding ABBV
Meristem Family Wealth's ABBV Position: Q1 2022 in Review
Meristem Family Wealth reduced its AbbVie (ABBV) stake by 17% in Q1 2022, selling an estimated $424K and leaving 14,317 shares worth $2.32M. The position accounts for 0.25% of the portfolio, ranked #45.
Meristem Family Wealth first reported a position in ABBV in Q2 2013 and has held it in 36 quarters since. The position peaked at $2.33M in Q4 2021. 3,053 funds tracked by Wall St. Rank hold ABBV as of Q1 2022.
- Meristem Family Wealth held 14,317 shares of AbbVie worth $2.32M as of Q1 2022.
- Meristem Family Wealth sold 2,920 AbbVie shares in Q1 2022, an estimated $424K.
- AbbVie made up 0.25% of Meristem Family Wealth's portfolio in Q1 2022, its #45 holding.
- Meristem Family Wealth first reported a position in AbbVie in Q2 2013 and has held it in 36 quarters since.
- Meristem Family Wealth's AbbVie position peaked at $2.33M in Q4 2021.
- 3,053 funds tracked by Wall St. Rank held AbbVie as of Q1 2022.
Based on Meristem Family Wealth's 13F filing for Q1 2022, filed 11 May 2022.